---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-127253"
form_type: "8-K"
ticker: "MREO"
cik: "0001719714"
company_name: "Mereo BioPharma Group plc"
filed_at: "2026-03-27T23:59:59+00:00"
generated_at: "2026-05-15T08:39:54.488585+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Dr. Annalisa Jenkins not seeking re-election to Mereo BioPharma board

## Summary
- Dr. Annalisa Jenkins will not stand for re-election at the 2026 AGM scheduled for May 14, 2026.
- Her decision did not result from any disagreement with the Company or Board on operations, policies, or practices.
- She will continue to serve as a director until her term expires immediately prior to the 2026 AGM.

## SEC filing metadata
- accession: 0001193125-26-127253
- form_type: 8-K
- ticker: MREO
- cik: 0001719714
- company_name: Mereo BioPharma Group plc
- filed_at: 2026-03-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719714/000119312526127253/0001193125-26-127253-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719714/000119312526127253/mreo-20260326.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-127253
- JSON: https://secwatch.observer/filing/0001193125-26-127253.json
- Plain text: https://secwatch.observer/filing/0001193125-26-127253.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.